Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -64,012 | -62,637 | -68,881 | -51,913 | -21,662 |
| Depreciation Amortization | 4,739 | 2,312 | -2,331 | 245 | 2,017 |
| Accounts receivable | 455 | 292 | -747 | N/A | 2,238 |
| Accounts payable and accrued liabilities | -1,353 | -3,554 | 4,821 | 1,231 | -409 |
| Other Working Capital | -6,890 | 2,730 | 1,360 | 14,909 | 261 |
| Other Operating Activity | 11,767 | 12,436 | 9,442 | 10,318 | 536 |
| Operating Cash Flow | $-55,294 | $-48,421 | $-56,336 | $-25,210 | $-17,019 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -20,619 | 51,614 | 72,209 | -36,564 | -89,551 |
| PPE Investments | -1,654 | -3,411 | -8,817 | -9,780 | -3,726 |
| Purchase Sale Intangibles | N/A | N/A | -2,500 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -2,500 | 0 | 0 |
| Investing Cash Flow | $-22,273 | $48,203 | $60,892 | $-46,344 | $-93,277 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 1,551 |
| Debt Issued | N/A | N/A | 4,199 | 3,735 | 1,242 |
| Debt Repayment | -2,200 | -1,696 | -1,169 | -455 | N/A |
| Common Stock Issued | 47,335 | 25,306 | 856 | 62,663 | 122,575 |
| Other Financing Activity | -704 | -1,360 | 2,245 | 2,072 | -860 |
| Financing Cash Flow | $44,431 | $22,250 | $6,131 | $68,015 | $124,508 |
| Beginning Cash Position | 55,070 | 33,038 | 22,351 | 25,890 | 11,678 |
| End Cash Position | 21,934 | 55,070 | 33,038 | 22,351 | 25,890 |
| Net Cash Flow | $-33,136 | $22,032 | $10,687 | $-3,539 | $14,212 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,294 | -48,421 | -56,336 | -25,210 | -17,019 |
| Capital Expenditure | -1,654 | -3,411 | -8,817 | -9,780 | -3,726 |
| Free Cash Flow | -56,948 | -51,832 | -65,153 | -34,990 | -20,745 |